The Valley Desk

NCT00233064 · Interventional trial

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Overall registry status Completed

Phase 4

Conditions Chronic Lung Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov